Replies to post #212737 on Biotech Values

[biopharm]

Evaluation of inflammatory markers after orthopedic surgical intervention in children.

Brdar R, Bukva B, Nikolic D, Petronic I, Golubovic Z, Abramovic D, Vidosavljevic M, Ducic S, Radlovic V, Cirovic D.
Abstract
OBJECTIVE:
The study aim was to evaluate inflammation markers values (C-reactive protein (CRP), Erythrocite sedimentation (ES), White blood cells count (WBC)) in surgically treated pediatric patients with diagnosed developmental displasia of the hip or Perthes disease before and after operation.

https://www.ncbi.nlm.nih.gov/pubmed/23445838

Laughs last for many more years after PS Targeting reduces inflammation

The biotech value = PS Targeting